US pharma major Merck & Co (NYSE: MRK) has shared the first results from a late-stage trial of a subcutaneous version of its ...

US clinical stage biopharma Candel Therapeutics (Nasdaq: CADL) has announced final survival data from a Phase IIa clinical ...

Japanese drugmaker Eisai says it has entered into an agreement to divest its rights for the oral anticoagulant warfarin (warfarin potassium) in Japan to Sawai . 28, 2025 ...

German drugmaker Bayer (BAYN: DE) has signed a global licensing agreement with China-based Puhe BioPharma, gaining exclusive ...

Under President Donald Trump’s new Secretary of Health and Human Services (HHS), the prominent vaccine sceptic Robert Francis ...

UK-based specialty pharma Kelso Pharma, which is backed by private equity investor Apposite Capital, announced that it has ...

US biotech Equillium reported Thursday that its lead drug candidate itolizumab failed to meet the main objective in a Phase ...

Genetic diseases company BridgeBio Pharma has announced that the Japanese Ministry of Health, Labor and Welfare has approved ...

The US Senate has confirmed President Donald Trump’s nominees to lead two of the country’s top health agencies, approving ...

Danish cancer specialist Genmab today announced that the Japanese Ministry of Health, Labor and Welfare has approved Tivdak ...

French biotech company Transgene (Euronext Paris: TNG) has reported its 2024 financial results and provided updates on its cancer immunotherapy pipeline. The company highlighted significant progress ...

Cambridge, USA-based RNS specialist Wave Life Sciences (Nasdaq: WVE) has announced positive data from the Phase II FORWARD-53 trial of WVE-N531, which is an exon skipping oligonucleotide being ...